Benjamin Harshbarger's most recent trade in Astria Therapeutics Inc was a trade of 262,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Astria Therapeutics Inc | Benjamin Harshbarger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 262,500 | 262,500 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Benjamin Harshbarger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Benjamin Harshbarger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Astria Therapeutics Inc | Benjamin Harshbarger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Astria Therapeutics Inc | Benjamin Harshbarger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Astria Therapeutics Inc | Benjamin Harshbarger | Senior VP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 400,000 | 400,000 | - | - | Stock Option (right to buy) |